PolyPeptide Group AG (XSWX:PPGN) Buildings And Improvements : CHF20.4 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Buildings And Improvements?

PolyPeptide Group AG's quarterly buildings and improvements declined from Dec. 2022 (CHF21.6 Mil) to Jun. 2023 (CHF0.0 Mil) but then increased from Jun. 2023 (CHF0.0 Mil) to Dec. 2023 (CHF20.4 Mil).

PolyPeptide Group AG's annual buildings and improvements increased from Dec. 2021 (CHF18.7 Mil) to Dec. 2022 (CHF21.6 Mil) but then declined from Dec. 2022 (CHF21.6 Mil) to Dec. 2023 (CHF20.4 Mil).

PolyPeptide Group AG Buildings And Improvements Historical Data

The historical data trend for PolyPeptide Group AG's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Buildings And Improvements Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

12.86

18.73

21.62

20.37

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Buildings And Improvements	Get a 7-Day Free Trial					18.73	-	21.62	-	20.37

PolyPeptide Group AG Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines